Professional Seasonal Analysis for Trading

Mirum Pharmaceuticals, Inc. - common stock (MIRM)

Seasonality Analysis

Stocks 7 Years Analyzed

Mirum Pharmaceuticals, Inc. - common stock Annual Seasonality Statistics

59.44%
Avg Annual Return
52.2%
Avg Monthly Win Rate
8/12
Positive Months
7
Years Analyzed

Mirum Pharmaceuticals, Inc. - common stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 5.83%
57%
Moderate
February 3.22%
43%
Weak
March -2.37%
57%
Weak
April 7.24%
57%
Moderate
May -5.47%
17%
Very Weak
June 8.32%
67%
Strong
July 6.69%
86%
Very Strong
August 11.59%
86%
Very Strong
September -0.14%
29%
Very Weak
October WORST -10.95%
14%
Very Weak
November 5.59%
57%
Moderate
December BEST 29.88%
57%
Moderate

Mirum Pharmaceuticals, Inc. - common stock 2026 vs Historical Pattern

Current Position
63.04
Historical Avg Position
33.57
Deviation
+29.47
Performance
Significantly Above Average

Mirum Pharmaceuticals, Inc. - common stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for MIRM with overlay patterns, custom date ranges, and more.

Create Free Account

Mirum Pharmaceuticals, Inc. - common stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Mirum Pharmaceuticals, Inc. - common stock Seasonal Historical Performance

Historical Performance

See historical average returns for MIRM across multiple timeframes.

Create Free Account

About Mirum Pharmaceuticals, Inc. - common stock (MIRM) Seasonality

Mirum Pharmaceuticals, Inc. - common stock (MIRM) has been analyzed using 7 years of historical data to identify seasonal patterns. Classified under Stocks, Mirum Pharmaceuticals, Inc. - common stock shows distinct seasonal tendencies based on historical data.

The strongest month for Mirum Pharmaceuticals, Inc. - common stock is historically December, with an average return of 29.88% and a win rate of 57%. Conversely, October tends to be the weakest month, averaging -10.95% return.

Looking at the full calendar year, Mirum Pharmaceuticals, Inc. - common stock has an average annual return of 59.44% with an overall monthly win rate of 52.2%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Mirum Pharmaceuticals, Inc. - common stock has a consistency score of 50.1 (Fair), based on 8 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Mirum Pharmaceuticals, Inc. - common stock Seasonality FAQ

What is the best month to buy Mirum Pharmaceuticals, Inc. - common stock (MIRM)?

Historically, December has been the best month for Mirum Pharmaceuticals, Inc. - common stock, with an average return of 29.88% and a win rate of 57%. However, past performance does not guarantee future results.

What is the worst month for Mirum Pharmaceuticals, Inc. - common stock (MIRM)?

Based on historical data, October has been the weakest month for Mirum Pharmaceuticals, Inc. - common stock, with an average return of -10.95%. This is a historical observation and does not guarantee future results.

How reliable is MIRM seasonality data?

The seasonality analysis for Mirum Pharmaceuticals, Inc. - common stock is based on 7 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Mirum Pharmaceuticals, Inc. - common stock seasonality in my trading?

Use Mirum Pharmaceuticals, Inc. - common stock (MIRM) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.